Schizophrenia

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Paola Dazzan, M.Sc. Ph.D. MRCPsych
Paola Dazzan, M.Sc. Ph.D. MRCPsych
November 18, 2011
Groundbreaking research led by Dr. Paola Dazzan, NARSAD Young Investigator Grantee, was recently featured on the BBC prime time show “Newsnight.” This new...
Aaron Beck, M.D.
Aaron Beck, M.D.
November 15, 2011
From The Quarterly, Fall 2011 Recent Foundation-funded research led by NARSAD Distinguished Investigator Grantee Aaron Beck, M.D. at the University of...
Jennifer Gottlieb, Ph.D., NARSAD YI, Dartmouth Medical School
Jennifer Gottlieb, Ph.D.
November 15, 2011
From The Quarterly, Fall 2011 Upwards of half of people taking antipsychotic medications continue to have some symptoms of psychosis. Cognitive behavioral...
Pablo Gejman, M.D.
Pablo Gejman, M.D.
November 15, 2011
From The Quarterly, Fall 2011 Genome-wide association studies (GWAS), begun in 2005 as a coordinated international effort to search for genes associated with...
Stephen Maguire
Stephen Maguire
November 15, 2011
Overcoming the challenge of living with symptoms of schizophrenia and bipolar disorder – a mix seen more often in men From The Quarterly, Fall 2011 Stephen...

Pages

Subscribe to